Home

Laos Soportar minusválido achim aigner leipzig university germany Analista Bergantín Moderar

Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and  Myocardin-Related Transcription Factors (MRTFs), Con
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Con

Advancing the use of noncoding RNA in regulatory toxicology: Report of an  ECETOC workshop
Advancing the use of noncoding RNA in regulatory toxicology: Report of an ECETOC workshop

Loop | Achim Aigner
Loop | Achim Aigner

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Perspectives, issues and solutions in RNAi therapy: the expected and the  less expected
Perspectives, issues and solutions in RNAi therapy: the expected and the less expected

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon  Carcinoma
Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards  Therapy
MicroRNAs (miRNAs) in Colorectal Cancer: From Aberrant Expression Towards Therapy

Achim Aigner - AD Scientific Index 2023
Achim Aigner - AD Scientific Index 2023

Analysis of cellular and molecular antitumor effects upon inhibition of  SATB1 in glioblastoma cells
Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells

Pharmaceutics & Novel Drug Delivery Systems
Pharmaceutics & Novel Drug Delivery Systems

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated  siRNA in a Syngeneic Orthotopic Mouse Glioma Model
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model

SI MedChemComm revision
SI MedChemComm revision

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology | Research profile
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology | Research profile

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma